Cargando…
Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840718/ https://www.ncbi.nlm.nih.gov/pubmed/29510679 http://dx.doi.org/10.1186/s12882-018-0844-2 |
_version_ | 1783304630090858496 |
---|---|
author | Su, Hua Ye, Chen Wen, Qian Zhu, Hong-Yan Yi, Li-Xia Zhang, Chun |
author_facet | Su, Hua Ye, Chen Wen, Qian Zhu, Hong-Yan Yi, Li-Xia Zhang, Chun |
author_sort | Su, Hua |
collection | PubMed |
description | BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed acute renal injury with proteinuria after CM administration. To our surprise, in his renal biopsy sample the myelin figure like structure was observed in glomerular endothelium and mesangial cells by transmission electron microscopy. However the patient didn’t has any clinic clues of Fabry disease and other lysosomal storage disorders. Moreover in vitro cultured glomerular endothelial and mesangial cells we found CM triggers lipid aggregation along with the increased CD36 and decreased ABCA1 abundance. Thus this patient was administrated statin to correct the aberrant lipid trafficking, 2 months later at his next visit we found his renal function partially recovered with reduced proteinuria. CONCLUSIONS: Besides the well-known underlying mechanisms, CM may cause renal impairment by triggering the dysregulated transportation of lipid. Furthermore statin is suggested to be a very promising medicine to decrease side effects of CM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-0844-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5840718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58407182018-03-09 Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection Su, Hua Ye, Chen Wen, Qian Zhu, Hong-Yan Yi, Li-Xia Zhang, Chun BMC Nephrol Case Report BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed acute renal injury with proteinuria after CM administration. To our surprise, in his renal biopsy sample the myelin figure like structure was observed in glomerular endothelium and mesangial cells by transmission electron microscopy. However the patient didn’t has any clinic clues of Fabry disease and other lysosomal storage disorders. Moreover in vitro cultured glomerular endothelial and mesangial cells we found CM triggers lipid aggregation along with the increased CD36 and decreased ABCA1 abundance. Thus this patient was administrated statin to correct the aberrant lipid trafficking, 2 months later at his next visit we found his renal function partially recovered with reduced proteinuria. CONCLUSIONS: Besides the well-known underlying mechanisms, CM may cause renal impairment by triggering the dysregulated transportation of lipid. Furthermore statin is suggested to be a very promising medicine to decrease side effects of CM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-0844-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-06 /pmc/articles/PMC5840718/ /pubmed/29510679 http://dx.doi.org/10.1186/s12882-018-0844-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Su, Hua Ye, Chen Wen, Qian Zhu, Hong-Yan Yi, Li-Xia Zhang, Chun Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
title | Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
title_full | Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
title_fullStr | Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
title_full_unstemmed | Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
title_short | Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
title_sort | case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840718/ https://www.ncbi.nlm.nih.gov/pubmed/29510679 http://dx.doi.org/10.1186/s12882-018-0844-2 |
work_keys_str_mv | AT suhua casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection AT yechen casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection AT wenqian casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection AT zhuhongyan casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection AT yilixia casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection AT zhangchun casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection |